Skip to main content
Erschienen in: Reactions Weekly 1/2008

01.10.2008 | Case report

Loratadine

Fixed drug eruptions: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Excerpt

A 64-year-old man started taking intermittent loratadine [Restamine; dosage not stated] for rhinitis in December 2007. By April 2008, he had experienced several episodes of fixed drug eruptions with numerous 2-5cm lesions following loratadine intake [times to reaction onsets not stated]. Lesions affected his arms, hands, back, neck, sacral region and buttocks, and resolved with residual hyperpigmentation. A few hours after loratadine intake on 24 April 2008, he presented with reactivation of previous lesions, as well as new-onset of macular erythematous lesions. Loratadine was discontinued and his fixed drug eruption did not recur.Author Comment“Diagnosis of fixed drug eruption due to loratadine was established in front of recurrent episodes of fixed drug eruption closely related to intermittent administration of loratadine and the positive rechallenge.” …
Literatur
1.
Zurück zum Zitat Kastalli S, El Aïdli S, Zaïem A, Cherif F, Daghfous R, Belkahia C.Recurrent fixed drug eruption due to loratadine. Drug Safety 31: 946 abstr. 166, No. 10, 2008 - Tunisia Kastalli S, El Aïdli S, Zaïem A, Cherif F, Daghfous R, Belkahia C.Recurrent fixed drug eruption due to loratadine. Drug Safety 31: 946 abstr. 166, No. 10, 2008 - Tunisia
Metadaten
Titel
Loratadine
Fixed drug eruptions: case report
Publikationsdatum
01.10.2008
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2008
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-200812220-00069

Weitere Artikel der Ausgabe 1/2008

Reactions Weekly 1/2008 Zur Ausgabe

Case report

Infliximab

Case report

Pioglitazone

Case report

Heparin

Case report

Epoprostenol

Case report

Aripiprazole

Case report

Timolol